angiotensin ii has been researched along with Muscular Dystrophy, Duchenne in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capogrosso, RF; Cozzoli, A; De Luca, A; Dinardo, MM; Gagliardi, S; Longo, V; Montagnani, M; Nico, B; Sblendorio, VT | 1 |
1 other study(ies) available for angiotensin ii and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Humans; Male; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Oxidative Stress | 2011 |